臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationDispense: 爽胰達注射劑100單位+50微克藥品配藥資料

Generated Narrative: MedicationDispense med-dis-injection-example

status: Completed

category: Inpatient

medication: 爽胰達注射劑100單位+50微克

subject: 陳加玲(official) Female, DoB: 1990-01-01 ( Medical record number (use: official, ))

context: Encounter: identifier = http://healthcare.example.org/identifiers/enocunter#E22081702; status = finished; class = pre-admission (ActCode#PRENC); type = Annual diabetes mellitus screening; serviceType = Nephrology (qualifier value); period = 2022-08-01 17:00:14+0800 --> 2022-08-01 18:00:14+0800; reasonCode = FH: Diabetes mellitus

Performers

-Actor
*Practitioner 陳耀詩(official)

type: Daily Fill

quantity: 1 Intravenous Solution (Details: Orderable Drug Form codeIVSOL = 'Intravenous Solution')

daysSupply: 3 days

whenPrepared: 2022-08-01 11:45:00+0800

whenHandedOver: 2022-08-01 12:00:00+0800

DosageInstructions

-TextTiming
*每日注射一次，於餐前一小時內注射，建議固定在同一餐的餐前注射Once per 1 days

Substitutions

-WasSubstitutedTypeReason
*falsenoneformulary policy